ctrl K

Tarsus Pharmaceuticals In... (TARS)

NASDAQ: TARS · Real-Time Price · USD

50.40

-1.51 (-2.91%)

At close: May 01, 2025, 3:59 PM

50.00

-0.79%

After-hours: May 01, 2025, 07:40 PM EDT

Tarsus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	182.95M	17.45M	25.82M	57.03M	n/a	n/a	n/a
Cost of Revenue	12.83M	1.59M	955K	2.08M	246K	74K	1K
Gross Profit	170.13M	15.85M	24.86M	54.95M	-246K	-74K	-1K
Operating Income	-120.57M	-143.16M	-62.71M	-12.16M	-27M	-4.3M	-1.35M
Interest Income	15.01M	10.34M	3.5M	36K	188K	40K	n/a
Pretax Income	-115.55M	-135.89M	-62.09M	-13.77M	-26.81M	-4.67M	-1.32M
Net Income	-115.55M	-135.89M	-62.09M	-13.83M	-26.81M	-4.67M	-1.32M
Selling & General & Admin	237.31M	108.7M	44.95M	25.4M	8.17M	1.14M	449K
Research & Development	53.39M	50.31M	42.62M	41.71M	18.83M	3.16M	901K
Other Expenses	n/a	n/a	86K	-73K	n/a	n/a	n/a
Operating Expenses	290.7M	159.01M	87.57M	67.11M	27M	4.3M	1.35M
Interest Expense	7.45M	3.35M	2.2M	n/a	188K	40K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	303.52M	160.6M	88.53M	69.18M	27M	4.3M	1.35M
Income Tax Expense	n/a	n/a	-4K	55K	1K	1K	1K
Shares Outstanding (Basic)	37.6M	29.38M	24.62M	20.55M	20.32M	19.51M	4.29M
Shares Outstanding (Diluted)	37.6M	29.38M	24.62M	20.55M	20.32M	19.51M	4.29M
EPS (Basic)	-3.07	-4.62	-2.52	-0.67	-1.32	-0.24	-0.31
EPS (Diluted)	-3.07	-4.62	-2.52	-0.67	-1.32	-0.24	-0.31
EBITDA	-106.88M	-131.67M	-59.11M	-13.17M	-26.56M	-4.55M	-1.35M
EBIT	-108.11M	-132.67M	-59.9M	-13.77M	-27M	-4.3M	-1.35M
Depreciation & Amortization	1.23M	877K	789K	606K	246K	74K	1K